FSHD2

Clinical trials for FSHD2 explained in plain language.

Never miss a new study

Get alerted when new FSHD2 trials appear

Sign up with your email to follow new studies for FSHD2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New hope for FSHD: Long-Term drug safety trial underway

Disease control Ongoing

This study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …

Matched conditions: FSHD2

Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

FSHD2

Get alerted when new FSHD2 trials appear

New hope for FSHD: Long-Term drug safety trial underway